NASHVILLE, Tenn. (WKRN)– Jeffrey Caruth credits an investigational treatment called Monoclonal Antibodies for helping him recover from COVID-19.
“I feel that if I hadn’t gotten that treatment, I’m afraid of the possibilities of what could have happened,” says Caruth.
Sick and quarantined, he struggled to breathe.
“It just scares you, you know? It’s not something normal that you really have in your life.”
Praying for relief, he traveled to Vanderbilt where he was hooked to an IV for an hour receiving laboratory-made antibodies that target and neutralizes the SARS-CoV-2 virus known as COVID-19.
“I didn’t feel like anything progressed,” Caruth explains. “I felt like I was at the same, which made me happy. And then, as another day went by, I was feeling a little bit better.”
Caruth, like so many others considered high-risk, experienced an improved outcome following treatment. In fact, data shows 97% of those who received the